Who are yellow fever vaccine (YFV)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Zostavax vaccine, Live Smallpox Vaccine, mOPV1, Live attenuated HAV vaccine, Varicella Vaccine, oral polio vaccine + information.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/yellow-fever-vaccine-yfv.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

yellow fever vaccine (YFV) — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

yellow fever vaccine (YFV) (yellow fever vaccine (YFV)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology / Infectious Disease.

marketed Live attenuated vaccine Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

yellow fever vaccine (YFV) (yellow fever vaccine (YFV)) — PATH. Yellow fever vaccine stimulates the immune system to produce antibodies and cellular immunity against yellow fever virus through a live attenuated viral strain.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
yellow fever vaccine (YFV) TARGET	yellow fever vaccine (YFV)	PATH	marketed	Live attenuated vaccine
Zostavax vaccine	Zostavax vaccine	Oklahoma Medical Research Foundation	marketed	Live attenuated vaccine	Varicella-zoster virus (VZV)
Live Smallpox Vaccine	Live Smallpox Vaccine	Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"	marketed	Live attenuated vaccine	Vaccinia virus antigens (envelope and intracellular proteins)
mOPV1	mOPV1	Aga Khan University	marketed	Live attenuated vaccine	Poliovirus type 1
Live attenuated HAV vaccine	Live attenuated HAV vaccine	Sinovac Biotech Co., Ltd	marketed	Live attenuated vaccine
Varicella Vaccine	Varicella Vaccine	Novartis	marketed	Live attenuated vaccine	Varicella-zoster virus (VZV)
oral polio vaccine + information	oral polio vaccine + information	Bandim Health Project	marketed	Live attenuated vaccine	Poliovirus types 1, 2, and 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

GlaxoSmithKline · 19 drugs in this class
Merck Sharp & Dohme LLC · 11 drugs in this class
Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
PATH · 5 drugs in this class
Sanofi · 5 drugs in this class
Bandim Health Project · 5 drugs in this class
Centers for Disease Control and Prevention · 3 drugs in this class
International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
Beijing Center for Disease Control and Prevention · 2 drugs in this class
Aga Khan University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). yellow fever vaccine (YFV) — Competitive Intelligence Brief. https://druglandscape.com/ci/yellow-fever-vaccine-yfv. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab